Corporate News     13-Mar-20
AstraZeneca receives import and market permission for Acalabrutinib 100mg capsules
From Drugs Controller General of India
AstraZeneca Pharma India has received Import and Market permission in Form CT-20 (Marketing Authorization- Additional Indication) from the Drugs Controller General of India for Acalabrutinib 100mg capsules (Calquence®).

The receipt of this Import and Market permission paves way for the launch of Acalabrutinib 100mg capsules (Calquence®) in India, subject to the receipt of related statutory approvals and licenses.

Acalabrutinib 100mg capsules is indicated for treatment of patients with chronic lymphocytic leukaemia (CLL)/ small lymphocytic lymphoma (SLL).

Previous News
  Astrazeneca Pharma India fixes record date for interim dividend
 ( Market Beat - Reports 11-Aug-20   09:31 )
  Astrazeneca Pharma gains after CDSCO nod to sale Tremelimumab solution
 ( Hot Pursuit - 02-Jun-23   10:05 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 03-Nov-21   16:58 )
  Board of Astrazeneca Pharma India recommends interim dividend
 ( Corporate News - 11-Aug-20   09:34 )
  Astrazeneca Pharma India Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Feb-24   15:00 )
  Astrazeneca Pharma India standalone net profit declines 53.97% in the June 2017 quarter
 ( Results - Announcements 09-Aug-17   17:10 )
  Astrazeneca Pharma India to convene board meeting
 ( Corporate News - 13-May-20   09:10 )
  Astrazeneca Pharma India standalone net profit rises 204.97% in the March 2019 quarter
 ( Results - Announcements 25-May-19   15:13 )
  Strides Pharma Science Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Jul-19   12:00 )
  Astrazeneca Pharma India reports standalone net loss of Rs 13.41 crore in the December 2014 quarter
 ( Results - Announcements 12-Feb-15   11:17 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 22-Jan-20   10:30 )
Other Stories
  Adani Ports records 14% growth in cargo volumes in September 2024
  03-Oct-24   09:37
  SignatureGlobal India launches new project in Gurugram
  03-Oct-24   09:34
  Biocon Biologics refinances debt through USD bonds and syndicated term loan
  03-Oct-24   09:29
  RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
  03-Oct-24   09:26
  Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
  03-Oct-24   09:23
  Transformers & Rectifiers India wins order of Rs 565 cr
  03-Oct-24   09:07
  Tata Motors records 12% decline in Q2 sales
  01-Oct-24   18:04
  Tata Motors records 15% decline in September sales
  01-Oct-24   17:55
  Man Infra set to launch its highly anticipated Vile Parle project
  01-Oct-24   17:48
  Padam Cotton Yarns to declare Quarterly Result
  01-Oct-24   17:39
Back Top